Resistance to Trastuzumab

SIMPLE SUMMARY: Trastuzumab is a humanized antibody that has significantly improved the management and treatment outcomes of patients with cancers that overexpress HER2. Many research groups, both in academia and industry, have contributed towards understanding the various mechanisms engaged by tras...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivekanandhan, Sneha, Knutson, Keith L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600208/
https://www.ncbi.nlm.nih.gov/pubmed/36291900
http://dx.doi.org/10.3390/cancers14205115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600208/
https://www.ncbi.nlm.nih.gov/pubmed/36291900
http://dx.doi.org/10.3390/cancers14205115

Ejemplares similares